Inventor · disambiguated record
Sawsan Youssef
Also filed as: YOUSSEF SAWSAN
9 granted patents·12 pending applications·106 citations·filing 1998–2024
88Inventor score
Files withCENTIVAX INC7RINAT NEUROSCIENCE CORP4CHARLES RIVER LABORATORIES INC2DISTRIBUTED BIO INC2PANDION OPERATIONS INC1
Top patents by PatentIndex Score
21 records- 0194US10155037B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2015·Granted Dec 18, 2018·18 cites·45 claims
- 0293US11028167B1Anti-SARS-Cov-2 antibodies derived from 3bgfCENTIVAX INC·Filed 2020·Granted Jun 8, 2021·11 cites·21 claims
- 0393US11021531B1Anti-SARS-Cov-2 antibodies derived from 2GHWCENTIVAX INC·Filed 2020·Granted Jun 1, 2021·17 cites·16 claims
- 0492US11053304B1Anti-SARS-Cov-2 antibodies derived from 6nb6CENTIVAX INC·Filed 2020·Granted Jul 6, 2021·10 cites·21 claims
- 0592US11028150B1Anti-SARS-CoV-2 antibodies derived from 2DD8CENTIVAX INC·Filed 2020·Granted Jun 8, 2021·7 cites·21 claims
- 0691US11034762B1Anti-SARS-Cov-2 antibodies derived from CR3022CENTIVAX INC·Filed 2020·Granted Jun 15, 2021·4 cites·13 claims
- 0785US10660953B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2018·Granted May 26, 2020·2 cites·19 claims
- 0876US2022249657A1Anti-pd-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2022·Application pending·0 cites
- 0974US6316420B1DNA cytokine vaccines and use of same for protective immunity against multiple sclerosisTECHNION RES & DEV FOUNDATION·Filed 1998·Granted Nov 13, 2001·37 cites·4 claims
- 1070US11338035B2Anti-PD-1 antibodies and methods of use thereofRINAT NEUROSCIENCE CORP·Filed 2020·Granted May 24, 2022·0 cites·15 claims
- 1170US2025002582A1Targeted immunotolerance with a pd-1 agonistPANDION OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1261US2024270825A1Anti-sars-cov-2 antibodies derived from cr3022CENTIVAX INC·Filed 2023·Application pending·0 cites
- 1356US2022186209A1Methods of antibody panning against target proteinsCHARLES RIVER LABORATORIES INC·Filed 2022·Application pending·0 cites
- 1454US2021206856A1Targeted immunotolerance with a pd-1 agonistPANDION THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1551US2002086841A1DNA cytokine vaccines and use of same for protective immunity against multiple sclerosisFiled 2001·Application pending·0 cites
- 1650US2021147566A1Antibodies and uses thereofDISTRIBUTED BIO INC·Filed 2020·Application pending·0 cites
- 1749US2021060126A1Major histocompatibility complex (mhc) compositions and methods of use thereofDISTRIBUTED BIO INC·Filed 2020·Application pending·0 cites
- 1849US2022088175A1Optimized vaccine compositions and methods for making the sameCENTIVAX INC·Filed 2021·Application pending·0 cites
- 1949US2022154171A1Antigen binding molecules and methods of screening thereofCHARLES RIVER LABORATORIES INC·Filed 2022·Application pending·0 cites
- 2046US2008166339A1Inhibition of osteopontin for treatment of relapsing autoimmune diseaseYOUSSEF SAWSAN·Filed 2007·Application pending·0 cites
- 2140US2004002537A1Use of statins in the treatment of autoimmune diseaseFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sawsan Youssef files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →